SCHEMBL8005684

SCHEMBL8005684

COC(=O)OC(=Cc1ccc(F)cc1)C(=O)C1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.37
KMT2A Q03164 4/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NR1H4 Q96RI1 1/20 0.36
NPC1 O15118 3/20 0.36
ALDH1A1 P00352 1/20 0.36
DPEP1 P16444 1/20 0.35
TRPA1 O75762 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
ENPP3 O14638 1/20 0.34
ENPP1 P22413 1/20 0.34
ENPP2 Q13822 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8133007 0.78 MEN1 (0.48) RAB9AKMT2ALMNAMAPTMEN1
SCHEMBL8133010 0.78 MEN1 (0.48) RAB9AKMT2ALMNAMAPTMEN1
SCHEMBL9735963 0.75 MEN1 (0.50) KMT2ALMNAMAPTMEN1CYP1A2
SCHEMBL9735955 0.75 MEN1 (0.50) KMT2ALMNAMAPTMEN1CYP1A2
SCHEMBL9735962 0.75 MEN1 (0.50) KMT2ALMNAMAPTMEN1CYP1A2
SCHEMBL8876005 0.68 MEN1 (0.44) KMT2ALMNAMAPTMEN1CYP1A2
SCHEMBL8876007 0.68 MEN1 (0.44) KMT2ALMNAMAPTMEN1CYP1A2
SCHEMBL18060097 0.64 MEN1 (0.46) KMT2ALMNAMAPTMEN1NPSR1
SCHEMBL15573909 0.64 MEN1 (0.46) KMT2ALMNAMAPTMEN1NPSR1
SCHEMBL3921874 0.64 MAPT (0.67) KMT2ALMNAMAPTMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0968162-A1 5-HYDROXYALKYL SUBSTITUTED PHENYLS AND THEIR USE IN MEDICAMENTS FOR THE TREATMENT OF ARTERIOSCLEROSIS AND HYPERLIPOPROTEINAEMIA BAYER AG (DE) 2000-01-05 EP disclosed
WO-1998034895-A1 5-HYDROXYALKYL SUBSTITUTED PHENYLS AND THEIR USE IN MEDICAMENTS FOR THE TREATMENT OF ARTERIOSCLEROSIS AND HYPERLIPOPROTEINAEMIA BAYER AKTIENGESELLSCHAFT (DE) 1998-08-13 WO disclosed